CorMedix Inc.
DE ˙ DB ˙ US21900C3088
7,15 € ↑0,26 (3,77%)
2026-06-05
DEL PRIS
SecurityDE:19KA / CorMedix Inc.
InstitutionJane Street Group, Llc
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Jane Street Group, Llc ownership in 19KA / CorMedix Inc.

On May 12, 2026 - Jane Street Group, Llc filed a 13F-HR form disclosing ownership of 0 shares of CorMedix Inc. (DE:19KA) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 12, 2026 disclosing 274,630 shares of CorMedix Inc.. This represents a change in shares of -100.00% during the quarter. The current value of the position is $0 USD.

Jane Street Group, Llc has a history of taking positions in derivatives of the underlying security (19KA) in the form of stock options. The firm currently holds call options representing 218,400 of underlying shares valued at $1,482,936 USD and put options representing 177,700 of underlying shares valued at $1,206,583 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:19KA / CorMedix Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-12 2026-03-31 13F CORMEDIX COM 21900C308 0 -274,630 -100.00 0 -100.00
2026-02-12 2025-12-31 13F CORMEDIX COM 21900C308 274,630 62,961 29.75 3,194 29.74 0.0005
2025-11-14 2025-09-30 13F CORMEDIX COM 21900C308 211,669 -74,291 -25.98 2,462 -30.14 0.0004
2025-08-14 2025-06-30 13F CORMEDIX COM 21900C308 285,960 285,960 3,523 0.0007
2025-05-19 2025-03-31 13F/A-1 CORMEDIX COM 21900C308 0 -26,861 -100.00 0 -100.00
2025-05-14 2025-03-31 13F CORMEDIX COM 21900C308 0 -26,861 0
2025-02-14 2024-12-31 13F CORMEDIX COM 21900C308 26,861 -91,993 -77.40 218 -77.40 0.0000
2024-11-15 2024-09-30 13F CORMEDIX COM 21900C308 118,854 -2,734 -2.25 960 82.51 0.0002
2024-08-15 2024-06-30 13F CORMEDIX COM 21900C308 121,588 101,533 506.27 526 518.82 0.0001
2024-05-16 2024-03-31 13F CORMEDIX COM 21900C308 20,055 -43,555 -68.47 85 -64.44 0.0000
2024-02-15 2023-12-31 13F CORMEDIX COM 21900C308 63,610 31,670 99.15 239 102.54 0.0001
2023-11-15 2023-09-30 13F CORMEDIX COM 21900C308 31,940 31,940 118 0.0000
2023-08-14 2023-06-30 13F CORMEDIX COM 21900C308 0 -95,882 -100.00 0 -100.00
2023-05-16 2023-03-31 13F CORMEDIX COM 21900C308 95,882 95,882 397 0.0002
2021-11-16 2021-09-30 13F CORMEDIX COM 21900C308 0 -11,981 -100.00 0 -100.00
2021-08-16 2021-06-30 13F CORMEDIX COM 21900C308 11,981 -24,050 -66.75 82 -77.22 0.0000
2021-05-18 2021-03-31 13F CORMEDIX COM 21900C308 36,031 36,031 200.73 360 339.02 0.0002
2020-02-14 2019-12-31 13F CORMEDIX COM 21900C308 0 -15,153 -100.00 0 -100.00
2019-11-14 2019-09-30 13F CORMEDIX COM 21900C308 15,153 15,153 97 0.0002
2015-11-16 2015-09-30 13F CORMEDIX COM 21900C100 0 -18,939 -100.00 0 -100.00
2015-08-14 2015-06-30 13F CORMEDIX COM 21900C100 18,939 18,939 73 0.0005
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F CORMEDIX COM Call 218,400 177.86 1,483 62.14 n/a n/a n/a
2026-02-12 2025-12-31 13F CORMEDIX COM Call 78,600 -37.91 914 -37.91 n/a n/a n/a
2025-11-14 2025-09-30 13F CORMEDIX COM Call 126,600 27.75 1,472 20.66 n/a n/a n/a
2025-08-14 2025-06-30 13F CORMEDIX COM Call 99,100 8.66 1,221 117.47 n/a n/a n/a
2025-05-19 2025-03-31 13F/A CORMEDIX COM Call 91,200 31.03 562 -0.36 n/a n/a n/a
2025-05-14 2025-03-31 13F CORMEDIX COM Call 91,200 562 n/a n/a n/a
2025-02-14 2024-12-31 13F CORMEDIX COM Call 69,600 564 n/a n/a n/a
2023-11-15 2023-09-30 13F CORMEDIX COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F CORMEDIX COM Call 11,000 44 n/a n/a n/a
2021-11-16 2021-09-30 13F CORMEDIX COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F CORMEDIX COM Call 17,500 -63.00 120 -74.63 n/a n/a n/a
2021-05-18 2021-03-31 13F CORMEDIX COM Call 47,300 473 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-12 2026-03-31 13F CORMEDIX COM Put 177,700 -6.38 1,207 -45.36 n/a n/a n/a
2026-02-12 2025-12-31 13F CORMEDIX COM Put 189,800 160.00 2,207 160.26 n/a n/a n/a
2025-11-14 2025-09-30 13F CORMEDIX COM Put 73,000 274.36 849 253.33 n/a n/a n/a
2025-08-14 2025-06-30 13F CORMEDIX COM Put 19,500 -41.09 240 18.23 n/a n/a n/a
2025-05-19 2025-03-31 13F/A CORMEDIX COM Put 33,100 204 n/a n/a n/a
2025-05-14 2025-03-31 13F CORMEDIX COM Put 33,100 204 n/a n/a n/a
2023-11-15 2023-09-30 13F CORMEDIX COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2023-08-14 2023-06-30 13F CORMEDIX COM Put 10,700 42 n/a n/a n/a
2021-11-16 2021-09-30 13F CORMEDIX COM Put 0 -100.00 0 -100.00 n/a n/a n/a
2021-08-16 2021-06-30 13F CORMEDIX COM Put 10,700 73 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.